Beyond AFP (hepatocellular carcinoma), PSA (prostate cancer), and CA125 (ovarian cancer), which have relatively specific diagnostic value, other tumor markers must be comprehensively analyzed according to other clinical information from patients. The gene discussed is AFP; the disease is Familial prostate cancer.